Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Is ARRY A Good Stock To Buy Right Now?’

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Array Biopharma Inc (ARRY) Updates On COLUMBUS Phase 3 And It’s Impressive

Array Biopharma Inc (NASDAQ:ARRY) and its partner Pierre Fabre took the opportunity at the Society for Melanoma Research Annual Congress to share results......(read more)
engineering, lab, chemistry, test, experiment, reagents, technician, protective, pharmaceutical, researching, medical, liquid, chemist, bio, laboratory, clinic, substance,

Array Biopharma Inc (ARRY) Stock: Gaining Big On Clinical Data

Today is likely to be a very interesting day in the market following the Trump win. Nonetheless, Array Biopharma Inc (NASDAQ:ARRY) is skyrocketing, and......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, internet, male, drugstore, service,

What Are Array Biopharma Inc (ARRY)’s Chances Of PDUFA Success?

Array Biopharma Inc (NASDAQ:ARRY) just had its latest NDA accepted by the FDA, and the agency has put forward a PDUFA date for the candidate of June 30......(read more)

All You Need To Know About Array Biopharma Inc (ARRY)’s Upcoming NDA Submission

Array Biopharma Inc (NASDAQ:ARRY) just reported detailed topline from a recently completed oncology pivotal, and alongside the report, announced it expects......(read more)